Pharma-Bio Serv (PBSV) Capital Expenditures (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Capital Expenditures came in at $2321.0 in Q2 2026, down 45.49% on a YoY basis from $4258.0 in Q2 2025, and down 3.73% quarter-over-quarter from $2411.0 in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Capital Expenditures (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Capital Expenditures for 17 consecutive years, with $2321.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Capital Expenditures fell 45.49% year-over-year to $2321.0; the trailing twelve-month figure through Apr 2026 stood at $7118.0 (down 95.64% YoY), and the FY2025 full-year result was $6644.0, down 95.84% from the prior year.
- Capital Expenditures fell to $2321.0 in Q2 2026 per PBSV's latest filing, from $2411.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $157015.0 in Q4 2024 and bottomed at -$1580.0 in Q4 2023.
- Historically, Capital Expenditures has averaged $13175.9 across 5 years, with a median of $2087.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures tumbled 113.02% in 2023, then soared 10037.66% in 2024.
- Over 5 years, Capital Expenditures stood at $12137.0 in 2022, then plunged by 113.02% to -$1580.0 in 2023, then jumped by 10037.66% to $157015.0 in 2024, then plunged by 99.78% to $350.0 in 2025, then surged by 563.14% to $2321.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $2321.0, $2411.0, and $350.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 186.22 Mn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 69.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 19.92 Mn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 3.81 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 31.00 Mn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 13.93 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 24.82 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 11.27 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 10.73 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 2,321.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 2,321.00 |
| Jan 31, 2026 | 2,411.00 |
| Oct 31, 2025 | 350.00 |
| Jul 31, 2025 | 2,036.00 |
| Apr 30, 2025 | 4,258.00 |
| Oct 31, 2024 | 157,015.00 |
| Jul 31, 2024 | 1,908.00 |
| Jan 31, 2024 | 820.00 |
| Oct 31, 2023 | -1,580.00 |
| Apr 30, 2023 | 764.00 |
| Jan 31, 2023 | 8,067.00 |
| Oct 31, 2022 | 12,137.00 |
| Jul 31, 2022 | 2,087.00 |
| Apr 30, 2022 | 4,361.00 |
| Jan 31, 2022 | 684.00 |
| Oct 31, 2021 | -881.00 |
| Jul 31, 2021 | 7,110.00 |
| Apr 30, 2021 | 7,404.00 |
| Jan 31, 2021 | 2,568.00 |
| Oct 31, 2020 | 6,321.00 |